Next Article in Journal
Functional Characterisation of Bile Metagenome: Study of Metagenomic Dark Matter
Next Article in Special Issue
Laccase-Catalyzed Derivatization of Aminoglycoside Antibiotics and Glucosamine
Previous Article in Journal
PeaT1 and PeBC1 Microbial Protein Elicitors Enhanced Resistance against Myzus persicae Sulzer in Chili Capsicum annum L.
Previous Article in Special Issue
Genome and Secretome Analysis of Staphylotrichum longicolleum DSM105789 Cultured on Agro-Residual and Chitinous Biomass
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Laccase-Catalyzed Derivatization of Antibiotics with Sulfonamide or Sulfone Structures

1
Institute for Microbiology, University of Greifswald, Felix-Hausdorff-Str. 8, 17489 Greifswald, Germany
2
Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Felix-Hausdorff-Str. 8, 17489 Greifswald, Germany
3
Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489 Greifswald, Germany
*
Author to whom correspondence should be addressed.
Submission received: 18 August 2021 / Revised: 15 October 2021 / Accepted: 18 October 2021 / Published: 21 October 2021

Abstract

:
Trametes spec. laccase (EC 1.10.3.2.) mediates the oxidative coupling of antibiotics with sulfonamide or sulfone structures with 2,5-dihydroxybenzene derivatives to form new heterodimers and heterotrimers. These heteromolecular hybrid products are formed by nuclear amination of the p-hydroquinones with the primary amino group of the sulfonamide or sulfone antibiotics, and they inhibited in vitro the growth of Staphylococcus species, including multidrug-resistant strains.

1. Introduction

The evolution of antibiotic resistances amongst microorganisms is a global problem [1,2,3]. Because of this, novel antimicrobial substances and synthesis routes are needed. For this, enzymatic catalysis may be an alternative to conventional chemical synthesis processes [4,5]. The oxidoreductase laccase [E.C. 1.10.3.2, benzenediol:dioxygen oxidoreductase] possesses a number of advantages. The reactions can be performed under mild and environmentally friendly conditions, such as atmospheric pressure and room temperature. Additionally, no cofactors such as a coenzyme or NADPH are needed.
Different laccase-mediated reactions are possible [6,7,8,9]. The laccase substrates may be oxidized by the enzyme and can then react to form homomolecular products [10,11], or the oxidized substrate may react with other compounds, such as amines or thiols, resulting in heteromolecular products [12]. These hybrid products are formed by C−C [13,14], C−N [15,16], C−O [17], or C−S [18,19] bonds. In addition, the reactions may also lead to multiple bond formation by ring closure mechanisms [20,21].
These diverse reaction types resulted in the synthesis or derivatization of antitumor [22,23,24], antioxidative [25,26,27], or estrogenic [28,29] compounds. Additionally, the synthesis of antibiotics by homomolecular and heteromolecular reactions have also been described. Thus, the laccase-catalyzed dimerizations of different ortho-aminophenol derivatives by C=N and C−O bond formations resulted in phenoxazinone pigments proposed as antitumor antibiotics [30,31,32,33,34,35]. Additionally, the catalytic derivatization of β-lactam antibiotics has been of particular interest. Agematu et al. [36] described the laccase-mediated synthesis of homomolecular dimers from different esters of penicillin X. The dimers of the penicillin X methyl ester showed hardly any antibacterial activity. In contrast, the ortho-ortho coupling product formed from penicillin X pivaloyloxymethyl ester represented a precursor (prodrug) of the penicillin X dimer. However, the minimum inhibitory concentration was lower than that of penicillin X sodium salt [36]. The laccase-catalyzed oxidation of a cephalosporanic acid resulted in the formation of two diastereomers, which differed in their configuration at C−2′ and their antibacterial efficacy [37]. Nevertheless, both compounds showed lower activity than the parent compound. Furthermore, penicillins and cephalosporines with free amino groups were derivatized with dihydroxylated aromatic compounds resulting in the formation of heteromolecular products [38,39,40]. The newly synthesized heterodimers had a moderate to high growth inhibitory effect against various bacteria including multidrug-resistant Staphylococcus and Enterococcus species. The products possessed also in vivo efficacy against Staphyloccocus aureus in mice. Additionally, the dimers resulting from reactions of 2,5-dihydroxybenzoic acid derivatives and penicillins or cephalosporins showed no cytotoxicity [41,42].
Consequently, 2,5-dihydroxybenzene derivatives were used for the derivatization of sulfanilamide and structurally related substances. Sulfanilamide is a structural part of 4′-sulfonamide-2,4-diaminoazobenzene (trade name: Prontosil), which was the first antibiotic of the sulfonamide group. This antibiotic was used against Gram-positive cocci such as Streptococcus spp. involved in the induction of sepsis [43]. Because of their structural similarity, sulfonamide acts as an antagonist for para-aminobenzoic acid. This results in the inhibition of bacterial folic acid synthesis, which is essential for prokaryotes [44,45]. The antibacterial effect of the sulfone dapsone relies on the same antagonistic mechanism [46]. The increasing incidence of antibiotic resistance shows the need for the synthesis of novel compounds. In the present study, the extracellular laccase C of Trametes spec. was employed for the production of heterodimers in reactions of sulfanilamide and its derivatives with para-dihydroxylated aromatic substances. The resulting products were tested for their antibacterial efficacy and cytotoxicity to human cells.
Different Staphylococcus strains were chosen for the determination of the antibacterial efficacy of the products formed. S. aureus ATCC6538/DSM799 (American Type Culture Collection/German Collection of Microorganisms and Cell Cultures) and the patient-derived multidrug-resistant S. epidermidis 99847 were used. Additionally, the northern German epidemic MRSA (methicillin-resistant S. aureus; Norddeutscher Epidemiestamm), which is resistant to penicillin, oxacillin, gentamicin, erythromycin, clindamycin, oxytetracycline, trimethoprim-sulfamethoxazole, rifampicin, and ciprofloxacin was employed [47]. Cytotoxicity was tested in a neutral red uptake assay using FL cells (human amniotic epithelial cell line).

2. Materials and Methods

2.1. Enzyme

Extracellular laccase C of Trametes spec. (EC 1.10.3.2) with an activity of 800 nmol·mL−1·min−1 (substrate: 2,2′-amino-bis-3-ethylbenzthiazoline-6-sulfonic acid) was obtained from ASA Spezialenzyme (Wolfenbüttel, Germany) and used in all experiments.

2.2. Substrates and Conditions of Biotransformation

The antibiotics—sulfanilamide, sulfamerazine and dapsone (2 mM)—were dissolved in 60 mL sodium acetate buffer, 20 mM pH 5.6. After addition of laccase C, the 2,5-dihydroxybenzene derivatives—2,5-dihydroxy-N-(2-hydroxyethyl)benzamide, 2,5-dihydroxybenzoic acid methyl ester, 2,5-dihydroxyacetophenone, 2,5-dihydroxyphenylacetic acid, or 2,5-dihydroxy-1,4-benzenediacetic acid—were added (6 mL of a 20 mM solution in sodium acetate buffer, pH 5.6). The reaction mixtures were incubated for 6 h at room temperature (RT) with agitation at 400 rpm.
Chemicals were purchased from the commercial supplier Sigma-Aldrich (Steinheim, Germany) with the exception of 2,5-dihydroxy-N-(2-hydroxyethyl)benzamide purchased from Midori Kagaku Co (Tokyo, Japan).

2.3. Isolation of Biotransformation Products

The isolation of the coupling products was performed by solid phase extraction described in detail by Mikolasch et al. [38].

2.4. Analytical High-Performance Liquid Chromatography (HPLC)

Samples of the incubation mixture were analyzed by HPLC−UV/Vis detector for routine analyses [38].

2.5. Characterization of Biotransformation Products

Products were analyzed by mass spectrometry (LC/MS with API-ES in negative and positive modes). The nuclear magnetic resonance (NMR) spectra were obtained at 300 MHz (1H) in acetonitrile-d3. Chemical shifts (δ) are given in part per million (ppm) downfield relative to tetramethylsilane (TMS, SiMe4), and spin-spin coupling constants (J) are in Hz. Residual solvent central signal was recorded at δH = 1.93 ppm and δC = 1.3 ppm.
3,6-Dioxo-2-(4-sulfamoylanilino)cyclohexa-1,4-diene-1-carboxyl methyl ester 3a1. Yield 88%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 3.11 (s, 3H, H−8), 5.77 (s, 2H, H−8′), 6.70 (d, 3J = 10.15 Hz, 1H, H−5), 6.81 (d, 3J = 10.15 Hz, 1H, H−4), 7.25 (d, 3J = 8.75 Hz, 2H, H−2′, H−6′), 7.79 (d, 3J = 8.75 Hz, 2H, H−3′, H−5′), 13.41 (s, 1H, H−7′), 13C NMR (75 MHz, CH3CN-d3): δ 51.6 (C−8), 102.4 (C−1), 125.6 (C−2′, C−6′), 128.3 (C−3′, C−5′), 133.1 (C−5), 139.7 (C−4′), 141.1 (C−4), 145.5 (C−1′), 154.5 (C−2), 169.2 (C−7), 184.5 (C−3), 185.4 (C−6) ppm. LC/MS m/z 337.1 [M + H]+ API-ES pos. mode, 335.1 [M − H] API-ES neg. mode.
N-(2-Hydroxyethyl)-3,6-dioxo-2-(4-sulfamoylanilino)cyclohexa-1,4-diene-1-carboxamide 3b1. Yield 92%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 3.40 (m, 3J = 5.4 Hz, 2H, H−9), 3.59 (t, 3J = 5.4 Hz, 2H, H−10), 5.74 (s, 2H, H−8′), 6.63 (d, 3J = 10.25 Hz, 1H, H−5), 6.71 (d, 3J = 10.25 Hz, 1H, H−4), 7.26 (d, 3J = 8.7 Hz, 2H, H−2′, H−6′), 7.79 (d, 3J = 8.8 Hz, 2H, H−3′, H−5′), 9.49 (s(broad), 1H, H−8), 13.42 (s, 1H, H−7′), 13C NMR (75 MHz, CH3CN-d3): δ 42.3 (C−9), 61.4 (C−10), 101.4 (C−1), 125.2 (C−2′, C−6′), 128.1 (C−3′, C−5′), 133.3 (C−5), 139.9 (C−4′), 141.4 (C−4), 145.3 (C−1′), 153.5 (C−2), 170.2 (C−7), 184.6 (C−3), 185.5 (C−6) ppm. LC/MS m/z 366.1 [M + H]+ API-ES pos. mode, 364.1 [M − H] API-ES neg. mode.
4-(2-Acetyl-3,6-dihydroxy-anilino)benzenesulfonamide 3c2. Yield 10% (only available in a mixture with trimers), LC/MS m/z 323.1 [M + H]+, 345.1 [M + Na]+ API-ES pos. mode.
3,6-Dihydroxy-2-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]anilino]benzoic acid methyl ester 3d. Yield 81%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 2.32 (s, 3H, H−13′), 3.10 (s, 3H, H−8), 3.15 (s, 1H, H−8′), 6.65 (d, 3J = 8.9 Hz, 1H, H−5), 6.76 (d, 3J = 8.9 Hz, 1H, H−4), 6.86 (d, 3J = 5.1 Hz, 1H, H−11′), 7.25 (d, 3J = 8.7 Hz, 2H, H−2′, H−6′), 7.95 (d, 3J = 8.7 Hz, 2H, H−3′, H−5′), 8.27 (d, 3J = 5.1 Hz, 1H, H−12′), 13.41 (s, 1H, H−7′), 13C NMR (75 MHz, CH3CN-d3): δ 22.6 (C−13′), 51.7 (C−8), 114.5 (C−2′, C−6′), 115.1 (C−5), 118.3 (C−4), 120.2 (C−1), 120.4 (C−11′), 124.3 (C−2), 128.9 (C−3′, C−5′), 130.7 (C−4′), 146.1 (C−3), 148.3 (C−10′), 150.4 (C−6), 152.2 (C−1′), 156.3 (C−12′), 163.7 (C−9′), 167.4 (C−7) ppm. 1H and 13C NMR data resulted in hydroquinoid structure 3d2. LC/MS m/z 427.3 [M − H] API-ES neg. mode, 855 [2M − H] API-ES neg. mode, LC/MS data resulted in quinoid structure 3d1.
3,6-Dihydroxy-N-(2-hydroxyethyl)-2-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]anilino]benzamide 3e. Yield 93%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 2.32 (s, 3H, H−13′), 3.15 (s, 1H, H−8′), 3.35 (m, 3J = 5.5 Hz, 2H, H−9), 3.57 (t, 3J = 5.5 Hz, 2H, H−10), 6.63 (d, 3J = 8.9 Hz, 1H, H−5), 6.74 (d, 3J = 8.9 Hz, 1H, H−4), 6.86 (d, 3J = 5.1 Hz, 1H, H−11′), 7.23 (d, 3J = 8.7 Hz, 2H, H−2′, H−6′), 7.95 (d, 3J = 8.7 Hz, 2H, H−3′, H−5′), 8.27 (d, 3J = 5.1 Hz, 1H, H−12′), 9.45 (s, 1H, H−8), 13.30 (s, 1H, H−7′), 13C NMR (75 MHz, CH3CN-d3): δ 22.7 (C−13′), 42.1 (C−9), 61.2 (C−10), 114.3 (C−2′, C−6′), 115.5 (C−5), 118.6 (C−4), 120.5 (C−1), 120.7 (C−11′), 124.8 (C−2), 128.9 (C−3′, C−5′), 130.8 (C−4′), 146.2 (C−3), 148.2 (C−10′), 150.2 (C−6), 152.2 (C−1′), 156.1 (C−12′), 163.8 (C−9′), 167.3 (C−7) ppm. 1H and 13C NMR data resulted in hydroquinoid structure 3e2. LC/MS m/z 456.3 [M − H] API-ES neg. mode, 914 [2M − H] API-ES neg. mode, LC/MS data resulted in quinoid structure 3e1.
4-[(2-Acetyl-3,6-dioxo-cyclohexa-1,4-dien-1-yl)amino]-N-(4-methylpyrimidin-2-yl)benzenesulfonamide 3f1 and 4-(2-acetyl-3,6-dihydroxy-anilino)-N-(4-methylpyrimidin-2-yl)benzenesulfonamide 3f2. No yields of isolated products (only available in a mixture of dimers and trimers), LC/MS m/z 411.1 [M − H] API-ES neg. mode, 823 [2M − H] API-ES neg. mode, LC/MS m/z 413.1 [M − H] API-ES neg. mode, 827 [2M − H] API-ES neg. mode, LC/MS data resulted in quinoid and hydroquinoid structures.
4-[[5-Acetyl-3,6-dioxo-4-(4-sulfamoylanilino)cyclohexa-1,4-dien-1-yl]amino]benzene-sulfonamide 4c1. Yield 80%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 2.50 (s, 3H, H−8), 5.74 (s, 2H, H−8′), 5.77 (s, 2H, H−8′), 6.09 (s, 1H, H−4), 7.28 (d, 3J = 8.6 Hz, 2H, H−2′, H−6′), 7.48 (d, 3J = 8.6 Hz, 2H, H−2′, H−6′), 7.80 (d, 3J = 8.6 Hz, 2H, H−3′, H−5′), 7.87 (d, 3J = 8.6 Hz, 2H, H−3′, H−5′), 13.30 (s, 1H, H−7′), 13.42 (s, 1H, H−7′). LC/MS m/z 491.1 [M + H]+ API-ES pos. mode.
4-[[5-Acetyl-4-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]anilino]-3,6-dioxo-cyclohexa-1,4-dien-1-yl]amino]-N-(4-methylpyrimidin-2-yl)benzenesulfonamide 4f1 and 4-[3-acetyl-2,5-dihydroxy-4-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]anilino]anilino]-N-(4-methylpyrimidin-2-yl)benzenesulfonamide 4f2. No yields of isolated products (only available in a mixture of dimers and trimers), LC/MS m/z 673.4 [M − H] API-ES neg. mode, LC/MS m/z 675.4 [M − H] API-ES neg. mode, LC/MS data resulted in quinoid and hydroquinoid structure.
2-[3,6-Dihydroxy-2-(4-sulfamoylanilino)phenyl]acetic acid 5a. Yield 48%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 3.47 (s, 2H, H−7), 5.75 (s, 2H, H−8′), 6.78 (d, 3J = 8.6, 1H, H−5), 6.80 (d, 3J = 8.6, 1H, H−4), 7.53 (d, 3J = 8.7 Hz, 2H, H−2′, H−6′), 7.84 (d, 3J = 8.7 Hz, 2H, H−3′, H−5′), 13.41 (s, 1H, H−7′), 1H NMR data resulted in hydroquinoid structure 5a2. LC/MS m/z 335.1 [M − H] API-ES neg. mode, 671 [2M−H] API-ES neg. mode, LC/MS data resulted in quinoid structure 5a1.
2-[4-(Carboxymethyl)-3,6-dihydroxy-2-(4-sulfamoylanilino)phenyl]acetic acid 5b. Yield 35%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 3.44 (s, 2H, H−7), 3.51 (s, 2H, H−7), 5.77 (s, 2H, H−8′), 6.42 (s, 1H, H−5), 7.52 (d, 3J = 8.7 Hz, 2H, H−2′, H−6′), 7.81 (d, 3J = 8.7 Hz, 2H, H−3′, H−5′), 13.40 (s, 1H, H−7′), 1H NMR data resulted in hydroquinoid structure 5b2. LC/MS m/z 393.1 [M − H] API-ES neg. mode, 787 [2M−H] API-ES neg. mode, LC/MS data resulted in quinoid structure 5b1.
2-[2-[4-[(4-Methylpyrimidin-2-yl)sulfamoyl]anilino]-3,6-dioxo-cyclohexa-1,4-dien-1-yl]acetic acid 5c1 and 2-[3,6-dihydroxy-2-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]anilino]phenyl]acetic acid 5c2. No yields of isolated products. LC/MS m/z 427.1 [M − H] API-ES neg. mode, LC/MS m/z 429.1 [M − H] API-ES neg. mode, LC/MS data resulted in quinoid and hydroquinoid structure.
2-[4-(Carboxymethyl)-5-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]anilino]-3,6-dioxo-cyclohexa-1,4-dien-1-yl]acetic acid 5d1 and 2-[4-(carboxymethyl)-2,5-dihydroxy-3-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]anilino]phenyl]acetic acid 5d2. No yields of isolated products. LC/MS m/z 485.1 [M − H] API-ES neg. mode, LC/MS m/z 487.1 [M − H] API-ES neg. mode, LC/MS data resulted in quinoid and hydroquinoid structure.
2-[4-[4-[(2-Methoxycarbonyl-3,6-dioxo-cyclohexa-1,4-dien-1-yl)amino]phenyl]sulfonylanilino]-3,6-dioxo-cyclohexa-1,4-diene-1-carboxyl methyl ester 6a1. LC/MS m/z 577.1 [M + H]+ API-ES pos. mode, LC/MS data resulted in a quinoid structure.
N-(2-Hydroxyethyl)-2-[4-[4-[[2-(2-hydroxyethylcarbamoyl)-3,6-dioxo-cyclohexa-1,4-dien-1-yl]amino]phenyl]sulfonylanilino]-3,6-dioxo-cyclohexa-1,4-diene-1-carboxamide 6b1. LC/MS m/z 635.1 [M + H]+ API-ES pos. mode, LC/MS data resulted in a quinoid structure.
3,6-Dihydroxy-2-[4-[4-[(2-methoxycarbonyl-3,6-dioxo-cyclohexa-1,4-dien-1-yl)amino]phenyl]sulfonylanilino]benzoic acid methyl ester 6a2. LC/MS m/z 579.1 [M + H]+ API-ES pos. mode, LC/MS data resulted in a quinoid-hydroquinoid structure.
3,6-Dihydroxy-N-(2-hydroxyethyl)-2-[4-[4-[[2-(2-hydroxyethylcarbamoyl)-3,6-dioxo-cyclohexa-1,4-dien-1-yl]amino]phenyl]sulfonylanilino]benzamide 6b2. LC/MS m/z 637.1 [M + H]+ API-ES pos. mode, LC/MS data resulted in a quinoid-hydroquinoid structure.
2-[4-[4-(3,6-Dihydroxy-2-methoxycarbonyl-anilino)phenyl]sulfonylanilino]-3,6-dihydroxy-benzoic acid methyl ester 6a3. Yield 22%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 3.14 (s, 6H, H−8), 6.62 (d, 3J = 8.7 Hz, 2H, H−5), 6.78 (d, 3J = 8.7 Hz, 2H, H−4), 7.25 (d, 3J = 8.8 Hz, 4H, H−2′, H−6′), 7.85 (d, 3J = 8.8 Hz, 4H, H−3′, H−5′), 13.25 (s, 2H, H−7′). LC/MS m/z 581.1 [M + H]+ API-ES pos. mode, LC/MS and 1H NMR data resulted in a hydroquinoid structure.
2-[4-[4-[3,6-dihydroxy-2-(2-hydroxyethylcarbamoyl)anilino]phenyl]sulfonylanilino]-3,6-dihydroxy-N-(2-hydroxyethyl)benzamide 6b3. Yield 28%, 1H NMR (300 MHz, CH3CN-d3): δ (ppm) 3.25 (m, 3J = 5.4 Hz, 4H, H−9), 3.54 (t, 3J = 5.4 Hz, 4H, H−10), 6.61 (d, 3J = 8.7 Hz, 2H, H−5), 6.76 (d, 3J = 8.7 Hz, 2H, H−4), 7.28 (d, 3J = 8.8 Hz, 4H, H−2′, H−6′), 7.88 (d, 3J = 8.8 Hz, 4H, H−3′, H−5′), 9.45 (s, 2H, H−8), 13.25 (s, 2H, H−7′). LC/MS m/z 639.1 [M + H]+ API-ES pos. mode, LC/MS and 1H NMR data resulted in a hydroquinoid structure.

2.6. Determination of Antibacterial Activity

An agar diffusion method described by Mikolasch et al. [39] was used to determine the antibacterial activity in the range from 29 to 1490 nmol. In brief, sterile Mueller-Hinton II-Agar in petri dishes (Becton Dickinson Microbiology systems, Cockeysville, Maryland, U.S.A.) was inoculated with 200 µL of bacterial solution (bacterial cell suspension 15 × 107 cells). The bacterial strains Staphylococcus aureus ATCC6538/DSM799, northern German epidemic MRSA (methicillin-resistant S. aureus; Norddeutscher Epidemiestamm), and the multidrug-resistant strain isolated from patients S. epidermidis 99847 were used. The test substances were applied on sterile paper discs (Sensi-Disc, 6 mm diameter, Becton Dickinson Microbiology systems). Petri dishes were kept for 3 h in a refrigerator (for prediffusion) and were then incubated for 24 h at 37 °C. Average inhibition zone diameters were calculated from 3 replicates.

2.7. Cytotoxic Activity

Cytotoxicity was determined by a neutral red uptake assay using FL-cells, a human amniotic epithelial cell line, as reported previously [39].

3. Results

3.1. Biotransformation of Sulfanilamide and Sulfamerazine with 2,5-Dihydroxybenzoic Acid Methyl Ester, 2,5-Dihydroxy-N-(2-Hydroxyethyl)Benzamide, or 2,5-Dihydroxyacetophenone by Laccase

Laccase-mediated reactions of 2,5-dihydroxybenzoic acid methyl ester (1a) with sulfanilamide (2a) resulted in a heteromolecular hybrid dimer with quinoid structure (3a1). In a similar way, the reaction of 2,5-dihydroxy-N-(2-hydroxyethyl)benzamide (1b) with sulfanilamide (2a) resulted in the production of structure 3b1 (Figure 1 and Table 1).
2,5-Dihydroxyacetophenone (1c) reacts with 2a by laccase mediation to a heteromolecular hybrid dimer with the hydroquinoid structure 3c2, and to a heteromolecular hybrid trimer with quinoid structure 4c1. When sulfamerazine (2b) was used as reaction partner, the product pattern changed. The sulfonamide 2b reacted with 1a to form heteromolecular hybrid dimers, which showed hydroquinoid character (3d2) in NMR measurements and quinoid character (3d1) during LC/MS analyses. The same results were obtained for the laccase-mediated reaction of 1b with sulfamerazine (3e1, 3e2), whereas 1c reacted with this sulfonamide to yield a mixture of dimers (3f1, 3f2) and trimers (4f1, 4f2).
After separation of 3a1 and 3b1 by solid phase extraction, LC/MS analyses in negative and positive mode showed molecular masses of these products attributed to the formation of heteromolecular hybrid dimers each consisting of a structural part of a 2,5-dihydroxybenzene derivative (1a or 1b) coupled to 2a accompanied by the loss of four hydrogen atoms. These couplings were confirmed by the presence of characteristic signals for 1a or 1b and for 2a in the 1H NMR spectra of 3a1 and 3b1 as well as by the presence of all carbons of 1a or 1b and of 2a in the 13C−NMR spectra of the products, but two signals in the range of 180 ppm indicated a quinoid character of these products. The number of CH proton signals of 1a and 1b changed from three in the substrate, to two signals in the products. The multiplicity of the proton signals H−4 and H−5 indicated an additional substituent at the C−2 atom and the loss of a proton. The chemical shift to lower field of the H−4 and H−5 signals confirmed the presence of an electron-withdrawing group. Signals for phenolic hydroxyl groups could not be measured, but instead additional amine protons were detected. All analytical data confirmed the oxidation of the p-hydroquinone structure of 1a and 1b to a quinone. The heteromolecular hybrid dimers 3a1 and 3b1 were formed by nuclear amination of the p-hydroquinones 1a or 1b at the C−6 position with the primary amino group of 2a (Figure 1).
Educt 1c reacted with 2a to a heteromolecular hybrid dimer 3c2, which was only analyzed by LC/MS in positive mode in a mixture together with a heteromolecular hybrid trimer 4c1. From the LC/MS data of 3c2 we deduced a dimer with hydroquinoid structure. The product 4c1 was described by LC/MS and 1H NMR analyses. All data showed a heteromolecular hybrid trimer consisting of a structural part of 1c coupled to two molecules of 2a accompanied by the loss of six hydrogen atoms. The number of CH proton signals of 1c changed from three in the substrate, to one singlet in the product. The data of this proton signal H−4 indicated an additional substituent at the C−2 atom and a second substituent at the C−5 atom of the product. The chemical shift of the H−4 signal verified the presence of electron-withdrawing groups. Furthermore, the two amine protons detected confirmed the coupling of two molecules of 2a to one molecule of 1c accompanied by the formation of a heteromolecular hybrid trimer with quinoid structure 4c1.
Like the reactions of 1a or 1b with 2a, the reactions of 1a or 1b with sulfamerazine (2b) also showed the same reaction patterns. Whereas 1a or 1b each reacted with 2a to yield a heteromolecular hybrid dimer with clear quinoid structure (3a1 and 3b1), the reaction of 1a or 1b with 2b each resulted in a heteromolecular hybrid dimer, which yielded the hydroquinoid structures 3d2 and 3e2 by 1H NMR and 13C NMR, and as the quinoids 3d1 and 3e1 by LC/MS.
From the reaction of 1c with 2b only a product mixture could be isolated and measured by LC/MS. Data for heteromolecular hybrid dimers with quinoid 3f1 and hydroquinoid 3f2 structure and for heteromolecular hybrid trimers with quinoid 4f1 and hydroquinoid 4f2 structure were detected. In this case, pure substances could not be isolated.

3.2. Biotransformation of Sulfanilamide and Sulfamerazine with 2,5-Dihydroxyphenylacetic Acid or 2,5-Dihydroxy-1,4-Benzenediacetic Acid by Laccase

2,5-Dihydroxyphenylacetic acid (1d) or 2,5-dihydroxy-1,4-benzenediacetic acid (1e) coupled with sulfanilamide (2a) proceeded quite differently from 1a and 1b (Figure 2 and Table 2). Whereas 1a or 1b each reacted with 2a to yield a heteromolecular hybrid dimer with clear quinoid structure (3a1 and 3b1), the reaction of 1d or 1e with 2a each resulted in a heteromolecular hybrid dimer, which were determined to be the hydroquinoids 5a2 and 5b2 by 1H NMR and the quinoids 5a1 and 5b1 by LC/MS.
In contrast, the product formation of 1d or 1e with sulfamerazine (2b) was comparable to that of 1a or 1b. Thus, the respective heteromolecular hybrid dimers with quinoid and hydroquinoid structures were detected in all four reactions. The only difference is that 1d or 1e reacted with 2b only to a product mixture from which no pure substance could be isolated and only LC/MS measurements were possible whereas from the reaction of 1a or 1b with 2b products were isolated and analyzed both by LC/MS and by NMR. But all of these four reactions are expected to follow the same reaction mechanism. In general, the reactions of 1d or 1e with 2a or 2b did not lead to isolated pure substances whereas the reactions with 1a or 1b resulted in products, which could be isolated.

3.3. Biotransformation of Dapsone with 2,5-Dihydroxybenzoic Acid Methyl Ester or 2,5-Dihydroxy-N-(2-Hydroxyethyl)Benzamide by Laccase

The 2,5-dihydroxybenzoic acid methyl ester (1a) or 2,5-dihydroxy-N-(2-hydroxyethyl)benzamide (1b) reacted with dapsone (2c) as amino reaction partner by Michael addition resulting in heteromolecular products, which were detected by characteristic UV-Vis spectra on HPLC for both substances (Figure 3 and Table 3).
After purification of the products by solid phase extraction, mass spectometric analyses (LC/MS with API-ES in positive modus) of the compounds showed a molecular mass attributed to the coupling of two molecules of the laccase substrate 1a or 1b with one molecule of 2c accompanied by the loss of eight, six or four hydrogen atoms forming quinoid (6a1, 6b1), mixed quinoid-hydroquinoid (6a2, 6b2), and hydroquinoid trimers (6a3, 6b3). 1H NMR analyses of the products also indicated heteromolecular trimers in each reaction. The hydroquinoid trimers (6a3, 6b3) were the most prominent such structures determined.

3.4. Biological Activity of Biotransformation Products

The products 3a1 and 3b1 were those with the best supported structural data, and they were stable over a longer time period. Because of this, they were selected for assays of biological activity. The agar diffusion test was chosen for the determination of the antibacterial activity of the substances. Thereby, the size of the respective inhibition zone is a measure of the antibacterial efficacy.
Both of these products caused low to moderate growth inhibition of S. aureus and S. epidermidis strains, among them multidrug-resistant staphylococci (Table 4).
The educts 1a and 2a were not active against the strains tested, 1b showed only very low activity with the highest concentration used. This indicates that products with antimicrobial activity can be produced by laccase-mediated reactions from two initially very poorly active or inactive compounds.
HPLC measurements demonstrated good product stability for the compounds 3a1 and 3b1, which had been stored in solid form at 4 °C for several weeks. However, incubation of the compounds 3a1 and 3b1 in aqueous solutions at 30 °C resulted in decomposition within some hours. For these reasons, the survey of their antimicrobial effects was restricted to the agar diffusion test.
3a1 and 3b1 as well as 1a, 1b, and 2a showed no cytotoxicity against FL cells at concentrations of 12.5, 25, 50, and 100 µg/mL. The growth of FL-cells was comparable with control culture (100–96% vitality).

4. Discussion

Because of increasing bacterial resistance to therapeutically used drugs, there is an urgent need to develop new antimicrobial agents. The laccase-mediated reaction of penicillin and cephalosporanic acid derivatives resulted in a dimerization by C−C or C−O bond formation and the synthesis of diastereomers, respectively [36,37]. These homomolecular products showed antimicrobial activity. Additionally, the laccase-mediated C−N bond formation between different partners resulted in heteromolecular products with antibacterial efficacy [48,49]. Such aminations are consequently a suitable green method for the synthesis of novel antibiotics. Thus, penicillins [38,40,41], cephalosporins [39,40,42], and its basic structures [46] have been structurally altered to achieve advanced antibacterial activities, especially against multidrug-resistant organisms. Furthermore, derivatives of the isolated antibacterial agents corollosporine from the marine fungus Corollospora maritima [50] and the ganomycins from Ganoderma pfeifferi [51] were transformed by one pot laccase-mediated reactions to improve their biological activity [38,42,52].
The sulfonamides and sulfones are antibacterial drugs that have been used for a long time [45,46], but whose value has progressively declined due to the emergence of resistant strains [53,54,55]. We have here derivatized antimicrobial sulfonamides and sulfones by laccase. Heterodimers and heterotrimers were synthesized by laccase-catalyzed reactions of sulfonamide antibiotics or dapsone with 2,5-dihydroxybenzene derivatives via nuclear amination. The formation of dimers (3a3f, 5ad) was determined for all reactions of 2a, 2b with 1a1e. Trimers (4f, 6a, 6b) were only detected in the reactions of 2a, 2b with 1c and for 2c with 1a, 1b. The structure of these trimers differed depending on whether the starting compound possessed one (2a, 2b) or two free amino groups (2c) accessible for a reaction with the p-hydroquinones (1ac). Thus, the trimers formed with 2a or 2b consisted of one molecule 1c and two molecules of 2a or 2b, respectively, whereas the trimers with 2c were formed from two molecules of 1a or 1b and only one molecule of 2c.
The dimers and trimers were detected in hydroquinoid or quinoid form, as described previously for heterodimers as products of p-hydroquinones with amino compounds such as aminopyrazole carboxamide [56] or aminothiophenol [21]. Interestingly, for the trimers with 2c, also a mixed quinoid-hydroquinoid trimer was formed with one molecule of 1a or 1b as hydroquinone and one quinoid molecule of 1a or 1b.
The results regarding the biological activity showed that, with the exception of compound 1b, the educts showed no inhibiting effect against the tested Staphylococcus species. Compound 1b had low activity only at the highest concentration tested (1.27 µmol). In contrast, the products 3a1 and 3b1 were effective at concentrations between 0.14 to 0.74 µmol. This increase in antimicrobial activity of these products of laccase-catalyzed reactions is remarkable, given that previous attempts to use laccase-mediated transformation of β-lactam antibiotics (such as ampicillin, amoxicillin) did not lead to an increase in antibiotic efficacy [36,37,38].
The increased antibacterial efficacy for the products 3a1 and 3b1 in comparison to the educts as well as the inhibition of different Staphylococcus species, in particular the multidrug-resistant northern German epidemic MRSA, without toxicity for mammalian cells underlines the high potential of laccase-mediated reactions for the synthesis of novel antibiotics.

Author Contributions

Conceptualization, A.M. and V.H.; Investigation, A.M.; Supervision, A.M.; Writing—original draft, A.M. and V.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We thank R. Jack for help in preparing the manuscript. We thank M. Kindermann: S. Siegert and B. Witt for NMR data acquisition, and S. Sokolowski for LC/MS data acquisition.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Davies, J.; Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 2010, 74, 417–433. [Google Scholar] [CrossRef] [Green Version]
  2. Ventola, C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm. Ther. 2015, 40, 277–283. [Google Scholar]
  3. Guo, Y.; Song, G.; Sun, M.; Wang, J.; Wang, Y. Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front. Cell Infect. Microbiol. 2020, 10, 107. [Google Scholar] [CrossRef] [Green Version]
  4. Monti, D.; Ottolina, G.; Carrea, G.; Riva, S. Redox reactions catalyzed by isolated enzymes. Chem. Rev. 2011, 111, 4111–4140. [Google Scholar] [CrossRef]
  5. Sheldon, R.A.; Brady, D.; Bode, M.L. The Hitchhiker’s guide to biocatalysis: Recent advances in the use of enzymes in organic synthesis. Chem. Sci. 2020, 11, 2587–2605. [Google Scholar] [CrossRef] [Green Version]
  6. Witayakran, S.; Ragauskas, A.J. Synthetic applications of laccase in green chemistry. Adv. Synth. Catal. 2009, 351, 1187–1209. [Google Scholar] [CrossRef]
  7. Mogharabi, M.; Faramarzi, M.A. Laccase and laccase-mediated systems in the synthesis of organic compounds. Adv. Synth. Catal. 2014, 356, 897–927. [Google Scholar] [CrossRef]
  8. Romero-Guido, C.; Baez, A.; Torres, E. Dioxygen activation by laccases: Green chemistry for fine chemical synthesis. Catalysts 2018, 8, 223. [Google Scholar] [CrossRef] [Green Version]
  9. Sousa, A.C.; Martins, L.O.; Robalo, M.P. Laccases: Versatile biocatalysts for the synthesis of heterocyclic cores. Molecules 2021, 26, 3719. [Google Scholar] [CrossRef]
  10. Leonowicz, A.; Edgehill, R.U.; Bollag, J.-M. The effect of pH on the transformation of syringic and vanillic acids by the laccases of Rhizoctonia praticola and Trametes versicolor. Arch. Microbiol. 1984, 137, 89–96. [Google Scholar] [CrossRef]
  11. Ciecholewski, S.; Hammer, E.; Manda, K.; Bose, G.; Nguyen, V.T.H.; Langer, P.; Schauer, F. Laccase-catalyzed carbon-carbon bond formation: Oxidative dimerization of salicylic esters by air in aqueous solution. Tetrahedron 2005, 61, 4615–4619. [Google Scholar] [CrossRef]
  12. Mikolasch, A.; Schauer, F. Fungal laccases as tools for the synthesis of new hybrid molecules and biomaterials. Appl. Microbiol. Biot. 2009, 82, 605–624. [Google Scholar] [CrossRef] [PubMed]
  13. Bollag, J.-M.; Sjoblad, R.D.; Minard, R.D. Polymerization of phenolic intermediates of pesticides by a fungal enzyme. Experientia 1977, 33, 1564–1566. [Google Scholar] [CrossRef] [PubMed]
  14. Jonas, U.; Hammer, E.; Haupt, E.T.K.; Schauer, F. Characterisation of coupling products formed by biotransformation of biphenyl and diphenyl ether by the white rot fungus Pycnoporus cinnabarinus. Arch. Microbiol. 2000, 174, 393–398. [Google Scholar] [CrossRef] [PubMed]
  15. Tatsumi, K.; Wada, S.; Ichikawa, H.; Liu, S.Y.; Bollag, J.-M. Cross-coupling of a chloroaniline and phenolic-acids catalyzed by a fungal enzyme. Water Sci. Technol. 1992, 26, 2157–2160. [Google Scholar] [CrossRef]
  16. Niedermeyer, T.H.J.; Mikolasch, A.; Lalk, M. Nuclear amination catalyzed by fungal laccases: Reaction products of p-hydroquinones and primary aromatic amines. J. Org. Chem. 2005, 70, 2002–2008. [Google Scholar] [CrossRef] [PubMed]
  17. Bollag, J.-M.; Liu, S.-Y. Copolymerization of halogenated phenols and syringic acid. Pestic. Biochem. Phys. 1985, 23, 261–272. [Google Scholar] [CrossRef]
  18. Benfield, G.; Bocks, S.M.; Bromley, K.; Brown, B.R. Studies of fungal and plant laccases. Phytochemistry 1964, 3, 79–88. [Google Scholar] [CrossRef]
  19. Schlippert, M.; Mikolasch, A.; Hahn, V.; Schauer, F. Enzymatic thiol Michael addition using laccases: Multiple C-S bond formation between p-hydroquinones and aromatic thiols. J. Mol. Catal. B-Enzym. 2016, 126, 106–114. [Google Scholar] [CrossRef]
  20. Bhalerao, U.T.; Muralikrishna, C.; Rani, B.R. Laccase enzyme-catalyzed efficient synthesis of 3-substituted-1,2,4-triazolo (4,3-b) (4,1,2) benzothiadiazine-8-ones. Tetrahedron 1994, 50, 4019–4024. [Google Scholar] [CrossRef]
  21. Hahn, V.; Mikolasch, A.; Weitemeyer, J.; Petters, S.; Davids, T.; Lalk, M.; Lackmann, J.W.; Schauer, F. Ring-closure mechanisms mediated by laccase to synthesize phenothiazines, phenoxazines, and phenazines. ACS Omega 2020, 5, 14324–14339. [Google Scholar] [CrossRef]
  22. Anyanwutaku, I.O.; Petroski, R.J.; Rosazza, J.P. Oxidative coupling of mithramycin and hydroquinone catalyzed by copper oxidases and benzoquinone. Implications for the mechanism of action of aureolic acid antibiotics. Bioorg. Med. Chem. 1994, 2, 543–551. [Google Scholar] [CrossRef]
  23. Wellington, K.W.; Kolesnikova, N.I. A laccase-catalysed one-pot synthesis of aminonaphthoquinones and their anticancer activity. Bioorg. Med. Chem. 2012, 20, 4472–4481. [Google Scholar] [CrossRef]
  24. Zhang, Y.; Yao, Q.; Li, Z.; Yang, F.; Wang, F.; Liu, J. A one-pot process for synthesis of mitomycin analogs catalyzed by laccase/lipase optimized by response surface methodology. Eng. Life Sci. 2019, 19, 805–814. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Ünlü, A.E.; Prasad, B.; Anavekar, K.; Bubenheim, P.; Liese, A. Investigation of a green process for the polymerization of catechin. Prep. Biochem. Biotech. 2017, 47, 918–924. [Google Scholar] [CrossRef]
  26. Kurisawa, M.; Chung, J.E.; Uyama, H.; Kobayashi, S. Laccase-catalyzed synthesis and antioxidant property of poly (catechin). Macromol. Biosci. 2003, 3, 758–764. [Google Scholar] [CrossRef]
  27. Nicotra, S.; Cramarossa, M.R.; Mucci, A.; Pagnoni, U.M.; Riva, S.; Forti, L. Biotransformation of resveratrol: Synthesis of trans-dehydrodimers catalyzed by laccases from Myceliophtora thermophyla and from Trametes pubescens. Tetrahedron 2004, 60, 595–600. [Google Scholar] [CrossRef]
  28. Lugaro, G.; Carrea, G.; Cremonesi, P.; Casellato, M.M.; Antonini, E. Oxidation of steroid hormones by fungal laccase in emulsion of water and organic solvents. Arch. Biochem. Biophys. 1973, 159, 1–6. [Google Scholar] [CrossRef]
  29. Nicotra, S.; Intra, A.; Ottolina, G.; Riva, S.; Danieli, B. Laccase-mediated oxidation of the steroid hormone 17β-estradiol in organic solvents. Tetrahedron Asymmetry 2004, 15, 2927–2931. [Google Scholar] [CrossRef]
  30. Eggert, C.; Temp, U.; Dean, J.F.D.; Eriksson, K.E.L. Laccase-mediated formation of the phenoxazinone derivative, cinnabarinic acid. FEBS Lett. 1995, 376, 202–206. [Google Scholar] [CrossRef] [Green Version]
  31. Eggert, C. Laccase-catalyzed formation of cinnabarinic acid is responsible for antibacterial activity of Pycnoporus cinnabarinus. Microbiol. Res. 1997, 152, 315–318. [Google Scholar] [CrossRef]
  32. Osiadacz, J.; Al-Adhami, A.J.H.; Bajraszewska, D.; Fischer, P.; Peczynska-Czoch, W. On the use of Trametes versicolor laccase for the conversion of 4-methyl-3-hydroxyanthranilic acid to actinocin chromophore. J. Biotechnol. 1999, 72, 141–149. [Google Scholar] [CrossRef]
  33. Giurg, M.; Wiech, E.; Piekielska, K.; Gębala, M.; Młochowski, J.; Wolański, M.; Ditkowski, B.; Peczyńska-Czoch, W. A new approach to synthesis of questiomycin A: Oxidative cyclocondensation of ortho-aminophenol. Pol. J. Chem. 2006, 80, 297–306. [Google Scholar] [CrossRef]
  34. Giurg, M.; Piekielska, K.; Gębala, M.; Ditkowski, B.; Wolański, M.; Peczyńska-Czoch, W.; Młochowski, J. Catalytic oxidative cyclocondensation of o-aminophenols to 2-amino-3H-phenoxazin-3-ones. Synth. Commun. 2007, 37, 1779–1789. [Google Scholar] [CrossRef]
  35. Bruyneel, F.; Enaud, E.; Billottet, L.; Vanhulle, S.; Marchand-Brynaert, J. Regioselective synthesis of 3-hydroxyorthanilic acid and its biotransformation into a novel phenoxazinone dye by use of laccase. Eur. J. Org. Chem. 2008, 2008, 70–79. [Google Scholar] [CrossRef]
  36. Agematu, H.; Tsuchida, T.; Kominato, K.; Shibamoto, N.; Yoshioka, T.; Nishida, H.; Okamoto, R.; Shin, T.; Murao, S. Enzymatic dimerization of penicillin-X. J. Antibiot. 1993, 46, 141–148. [Google Scholar] [CrossRef]
  37. Agematu, H.; Kominato, K.; Shibamoto, N.; Yoshioka, T.; Nishida, H.; Okamoto, R.; Shin, T.; Murao, S. Transformation of 7-(4-hydroxyphenylacetamido) cephalosporanic acid into a new cephalosporin antibiotic, 7-[1-oxaspiro (2.5)octa-6-oxo-4,7-diene-2-carboxamido]cephalosporanic acid, by laccase. Biosci. Biotechnol. Biochem. 1993, 57, 1387–1388. [Google Scholar] [CrossRef] [Green Version]
  38. Mikolasch, A.; Niedermeyer, T.H.J.; Lalk, M.; Witt, S.; Seefeldt, S.; Hammer, E.; Schauer, F.; Gesell, M.; Hessel, S.; Jülich, W.D.; et al. Novel penicillins synthesized by biotransformation using laccase from Trametes spec. Chem. Pharm. Bull. 2006, 54, 632–638. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Mikolasch, A.; Niedermeyer, T.H.J.; Lalk, M.; Witt, S.; Seefeldt, S.; Hammer, E.; Schauer, F.; Salazar, M.G.; Hessel, S.; Jülich, W.D.; et al. Novel cephalosporins synthesized by amination of 2,5-dihydroxybenzoic acid derivatives using fungal laccases II. Chem. Pharm. Bull. 2007, 55, 412–416. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Mikolasch, A.; Wurster, M.; Lalk, M.; Witt, S.; Seefeldt, S.; Hammer, E.; Schauer, F.; Jülich, W.D.; Lindequist, U. Novel beta-lactam antibiotics synthesized by amination of catechols using fungal laccase. Chem. Pharm. Bull. 2008, 56, 902–907. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Mikolasch, A.; Manda, K.; Schlüter, R.; Lalk, M.; Witt, S.; Seefeldt, S.; Hammer, E.; Schauer, F.; Jülich, W.D.; Lindequist, U. Comparative analyses of laccase-catalyzed amination reactions for production of novel beta-lactam antibiotics. Biotechnol. Appl. Biochem. 2012, 59, 295–306. [Google Scholar] [CrossRef] [PubMed]
  42. Mikolasch, A.; Hildebrandt, O.; Schlüter, R.; Hammer, E.; Witt, S.; Lindequist, U. Targeted synthesis of novel beta-lactam antibiotics by laccase-catalyzed reaction of aromatic substrates selected by pre-testing for their antimicrobial and cytotoxic activity. Appl. Microbiol. Biotechnol. 2016, 100, 4885–4899. [Google Scholar] [CrossRef] [PubMed]
  43. Domagk, G. Chemotherapy of bacterial infections. Angew Chem.-Ger. Edit. 1935, 48, 657–667. [Google Scholar] [CrossRef]
  44. Sköld, O. Sulfonamide resistance: Mechanisms and trends. Drug Resist. Update 2000, 3, 155–160. [Google Scholar] [CrossRef] [PubMed]
  45. Wainwright, M.; Kristiansen, J.E. On the 75th anniversary of Prontosil. Dyes Pigments 2011, 88, 231–234. [Google Scholar] [CrossRef]
  46. Zhu, Y.I.; Stiller, M.J. Dapsone and sulfones in dermatology: Overview and update. J. Am. Acad. Dermatol. 2001, 45, 420–434. [Google Scholar] [CrossRef]
  47. Witte, W.; Braulke, C.; Cuny, C.; Heuck, D.; Kresken, M. Changing pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus from German hospitals. Infect. Cont. Hosp. Ep. 2001, 22, 683–686. [Google Scholar] [CrossRef]
  48. Hahn, V.; Mikolasch, A.; Wende, K.; Bartrow, H.; Lindequist, U.; Schauer, F. Synthesis of model morpholine derivatives with biological activities by laccase-catalysed reactions. Biotechnol. Appl. Biochem. 2009, 54, 187–195. [Google Scholar] [CrossRef]
  49. Mikolasch, A. Laccase-mediated synthesis of novel antibiotics and amino acid derivatives. In Pharmaceutical Biocatalysis: Chemoenzymatic Synthesis of Active Pharmaceutical Ingredients; Grunwald, P., Ed.; Jenny Stanford Publishing Pte. Ltd.: Singapore, 2019; pp. 219–268. [Google Scholar]
  50. Liberra, K.; Jansen, R.; Lindequist, U. Corollosporine, a new phthalide derivative from the marine fungus Corollospora maritima Werderm. 1069. Pharmazie 1998, 53, 578–581. [Google Scholar] [CrossRef]
  51. Mothana, R.A.; Jansen, R.; Jülich, W.D.; Lindequist, U. Ganomycins A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J. Nat. Prod. 2000, 63, 416–418. [Google Scholar] [CrossRef] [PubMed]
  52. Mikolasch, A.; Hessel, S.; Gesell Salazar, M.; Neumann, H.; Manda, K.; Gördes, D.; Schmidt, E.; Thurow, K.; Hammer, E.; Lindequist, U.; et al. Synthesis of new N-analogous corollosporine derivatives with antibacterial activity by laccase-catalyzed amination. Chem. Pharm. Bull. 2008, 56, 781–786. [Google Scholar] [CrossRef] [Green Version]
  53. Wise, E.M.; Abou-Donia, M.M. Sulfonamide resistance mechanism in Escherichia coli-R plasmids can determine sulfonamide-resistant dihydropteroate synthases. Proc. Natl. Acad. Sci. USA 1975, 72, 2621–2625. [Google Scholar] [CrossRef] [Green Version]
  54. Vedantam, G.; Nichols, B.P. Characterization of a mutationally altered dihydropteroate synthase contributing to sulfathiazole resistance in Escherichia coli. Microb. Drug Resist. 1998, 4, 91–97. [Google Scholar] [CrossRef] [PubMed]
  55. Fiebelkorn, K.R.; Crawford, S.A.; Jorgensen, J.H. Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents. Antimicrob. Agents Chemother. 2005, 49, 536–540. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Hahn, V.; Davids, T.; Lalk, M.; Schauer, F.; Mikolasch, A. Enzymatic cyclizations using laccases: Multiple bond formation between dihydroxybenzoic acid derivatives and aromatic amines. Green Chem. 2010, 12, 879–887. [Google Scholar] [CrossRef]
Figure 1. Laccase-mediated reactions of 2,5-dihydroxybenzene derivatives (1a1c) with sulfonamides (2a, 2b) for the synthesis of heterodimers and heterotrimers produced as shown in Table 1. (R1=OCH3, NH(CH2)2OH, CH3; R2=H, CNC(CH3)(CH)2N).
Figure 1. Laccase-mediated reactions of 2,5-dihydroxybenzene derivatives (1a1c) with sulfonamides (2a, 2b) for the synthesis of heterodimers and heterotrimers produced as shown in Table 1. (R1=OCH3, NH(CH2)2OH, CH3; R2=H, CNC(CH3)(CH)2N).
Microorganisms 09 02199 g001
Figure 2. Laccase-mediated reactions of 2,5-dihydroxyphenylacetic acid (1d) and 2,5-dihydroxy-1,4-benzenediacetic acid (1e) with sulfonamides (2a, 2b) for the synthesis of heterodimers produced as shown in Table 2. (R1=H, CH2COOH; R2=H, CNC(CH3)(CH)2N).
Figure 2. Laccase-mediated reactions of 2,5-dihydroxyphenylacetic acid (1d) and 2,5-dihydroxy-1,4-benzenediacetic acid (1e) with sulfonamides (2a, 2b) for the synthesis of heterodimers produced as shown in Table 2. (R1=H, CH2COOH; R2=H, CNC(CH3)(CH)2N).
Microorganisms 09 02199 g002
Figure 3. Laccase-mediated reactions of 2,5-dihydroxybenzene derivatives (1a, 1b) with dapsone (2c) for the synthesis of heterotrimers produced as shown in Table 3. (R1=OCH3, NH(CH2)2OH).
Figure 3. Laccase-mediated reactions of 2,5-dihydroxybenzene derivatives (1a, 1b) with dapsone (2c) for the synthesis of heterotrimers produced as shown in Table 3. (R1=OCH3, NH(CH2)2OH).
Microorganisms 09 02199 g003
Table 1. Heterodimers and heterotrimers produced by laccase-mediated reactions of 2,5-dihydroxybenzene derivatives (1a1c) and sulfonamides (2a, 2b).
Table 1. Heterodimers and heterotrimers produced by laccase-mediated reactions of 2,5-dihydroxybenzene derivatives (1a1c) and sulfonamides (2a, 2b).
Educts Products
Quinoid
Dimers
Hydroquinoid
Dimers
Quinoid
Trimers
Hydroquinoid
Trimers
1a
  8
R1=OCH3
2a

R2=H
3a1
  8
R1=OCH3
R2=H
nd 1ndnd
1b
  8 9 10
R1=NHCH2CH2OH
2a3b1
  8 9 10
R1=NHCH2CH2OH
R2=H
ndndnd
1c
  8
R1=CH3
2and3c2
  8
R1=CH3
R2=H
4c1
  8
R1=CH3
R2=H
nd
1a
  8
R1=OCH3
2b

R2=

Microorganisms 09 02199 i001
3d1
  8
R1=OCH3
R2=
Microorganisms 09 02199 i002
3d2
  8
R1=OCH3
R2=
Microorganisms 09 02199 i003
ndnd
1b
  8 9 10
R1=NHCH2CH2OH
2b3e1
  8 9 10
R1=NHCH2CH2OH
R2=
Microorganisms 09 02199 i004
3e2
  8 9 10
R1=NHCH2CH2OH
R2=
Microorganisms 09 02199 i005
ndnd
1c
  8
R1=CH3
2b3f1
  8
R1=CH3
R2=
Microorganisms 09 02199 i006
3f2
  8
R1=CH3
R2=
Microorganisms 09 02199 i007
4f1
  8
R1=CH3
R2=
Microorganisms 09 02199 i008
4f2
  8
R1=CH3
R2=
Microorganisms 09 02199 i009
1 not detected by the measurements used.
Table 2. Heterodimers produced by laccase-mediated reactions of 2,5-dihydroxyphenylacetic acid (1d) and 2,5-dihydroxy-1,4-benzenediacetic acid (1e) and sulfonamides (2a, 2b).
Table 2. Heterodimers produced by laccase-mediated reactions of 2,5-dihydroxyphenylacetic acid (1d) and 2,5-dihydroxy-1,4-benzenediacetic acid (1e) and sulfonamides (2a, 2b).
Educts Products
Quinoid
Dimers
Hydroquinoid
Dimers
1d
R1=H
2a

R2=H
5a1
R1=H
R2=H
5a2
R1=H
R2=H
1e
R1=CH2COOH
2a5b1
R1=CH2COOH
R2=H
5b2
R1=CH2COOH
R2=H
1d
R1=H
2b

R2=
Microorganisms 09 02199 i010
5c1
R1=H
R2=
Microorganisms 09 02199 i011
5c2
R1=H
R2=
Microorganisms 09 02199 i012
1e
R1=CH2COOH
2b
5d1
R1=CH2COOH
R2=
Microorganisms 09 02199 i013
5d2
R1=CH2COOH
R2=
Microorganisms 09 02199 i014
Table 3. Heterotrimers produced by laccase-mediated reactions of 2,5-dihydroxybenzene derivatives (1a, 1b) with dapsone (2c).
Table 3. Heterotrimers produced by laccase-mediated reactions of 2,5-dihydroxybenzene derivatives (1a, 1b) with dapsone (2c).
Educts Products
Quinoid TrimersMixed Quinoid-Hydroquinoid TrimersHydroquinoid Trimers
1a
  8
R1=OCH3
2c6a1
  8
R1=OCH3
6a2
  8
R1=OCH3
6a3
  8
R1=OCH3
1b
  8 9 10
R1=NHCH2CH2OH
2c6b1
  8 9 10
R1=NHCH2CH2OH
6b2
  8 9 10
R1=NHCH2CH2OH
6b3
  8 9 10
R1=NHCH2CH2OH
Table 4. Antimicrobial activity of products 3a1 and 3b1, educts 1a to 1b and 2a against different Staphylococcus species; Zones of inhibition are given in diameter [mm] including paper disc (6 mm).
Table 4. Antimicrobial activity of products 3a1 and 3b1, educts 1a to 1b and 2a against different Staphylococcus species; Zones of inhibition are given in diameter [mm] including paper disc (6 mm).
SubstanceAmount n [µmol]S. aureus ATCC6538S. aureus-Northern German Epidemic MRSAS. epidermidis 99847
1a (educt)0.069r *rr
0.30rrr
0.74rrr
1.49rrr
1b (educt)0.069rrr
0.30rrr
0.74rrr
1.49101010
2a (educt)0.058rrr
0.29rrr
0.73rrr
1.45rrr
3a1 (product of 1a and 2a)0.030rrr
0.15rrr
0.37r12r
0.74101612
3b1 (product of 1b and 2a)0.030rrr
0.15r18r
0.37202220
0.74222626
* resistant (no zone of inhibition).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mikolasch, A.; Hahn, V. Laccase-Catalyzed Derivatization of Antibiotics with Sulfonamide or Sulfone Structures. Microorganisms 2021, 9, 2199. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms9112199

AMA Style

Mikolasch A, Hahn V. Laccase-Catalyzed Derivatization of Antibiotics with Sulfonamide or Sulfone Structures. Microorganisms. 2021; 9(11):2199. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms9112199

Chicago/Turabian Style

Mikolasch, Annett, and Veronika Hahn. 2021. "Laccase-Catalyzed Derivatization of Antibiotics with Sulfonamide or Sulfone Structures" Microorganisms 9, no. 11: 2199. https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms9112199

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop